The global probiotic supplement sales are expected to reach USD 7,524.6 million in 2024. It is projected to exhibit steady growth during the forecast period, with global demand for probiotic supplements rising at 11.2% CAGR. The market is projected to reach USD 23,874.5 million by 2034.
Attributes | Key Insights |
---|---|
Estimated Global Probiotic Market Size (2024E) | USD 7,524.6 million |
Projected Probiotic Supplement Market Value (2034F) | USD 23,874.5 million |
Value-based CAGR (2024 to 2034) | 11.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global probiotic supplement market grew at a significant CAGR from 2019 to 2023.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The table below shows the estimated growth rates of several countries in the market. Brazil, China, and India are set to record high CAGRs of 9.1%, 9.0%, and 12.6%, respectively, through 2034.
Countries | Value-based CAGR (2024 to 2034) |
---|---|
United States | 8.1% |
Brazil | 9.1% |
United Kingdom | 8.5% |
China | 9.0% |
India | 12.6% |
By 2034, the United States is expected to surge at 8.1% CAGR. Consumers look for superior quality, safety, and efficacy in probiotic supplements. They are prompting companies to prioritize quality control and provide transparent information about their components and processes.
Consumers in the United States are becoming more aware of the importance of gut health and the role of probiotics in maintaining it, leading to a surging demand for probiotic supplements. Supplement’s with Flavors such as Berries, Peach and Mango are set to show higher sales over next few years
Probiotic supplement demand in China is anticipated to rise at a steady CAGR of 9.0% during the forecast period. The probiotic market is expanding due to increased accessibility through several retail channels, allowing customers to purchase products based on convenience and personal preferences.
The validation of probiotic ingredients-based supplements in China is enhancing research & development initiatives, improving medical understanding, and driving industry expansion.
The probiotic supplement market is projected to increase in India at a CAGR of 12.6% through 2034. Functional meals and beverages, such as yogurt, kefir, and probiotic injections, are gaining popularity among health-conscious customers due to their potential health benefits.
These items are fortified with probiotics, making them an easy way to incorporate probiotics into their diets. Manufacturers in India are incorporating probiotics into their products, creating innovative food and drink formulations. They are also offering specialized goods for specific demographics or medical needs.
The section below shows the saccharomyces segment dominating by bacteria type. The segment is expected to surge at a CAGR of 12.2% through 2034. Based on form, the capsule segment is anticipated to generate a dominant share through 2024. It is set to rise at a CAGR of 9.2% from 2024 to 2034.
Segment | Value-based CAGR (2024 to 2034) |
---|---|
Women (Customer Orientation w.r.t. Functionality) | 8.1% |
Saccharomyces (Bacteria Type) | 12.2% |
Health & Wellness Stores (Sales Channel) | 8.3% |
1 Billion to 5 Billion (CFU Count) | 7.2% |
Capsules (Form) | 9.2% |
Probiotic supplement manufacturers are actively working toward expanding the market and innovating their products. Leading players are taking key steps to meeting needs of quality and convenience while maintaining a competitive price. Key companies are directed toward mergers & acquisitions, partnerships, and collaborations to expand their market reach.
Key Industry Developments
The market is set to reach USD 7,524.6 million in 2024.
Demand for probiotic supplements is slated to expand at an 11.2% CAGR by 2034.
The market is set to reach USD 23,874.5 million in 2034.
Culturelle, Align, Billion Cheers, and Digestive Advantage are the key players.
Capsule segment is estimated to hold a significant market share in 2024.
1. Executive Summary 1.1. Global Market Outlook 1.2. Segmental Share Analysis 1.3. Dynamics Snapshot 1.4. Wheel of Fortune 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition 3. Market Dynamics 3.1. Drivers 3.1.1. Supply Side Drivers 3.1.2. Demand Side drivers 3.1.3. Economic Side Drivers 3.2. Restraints 3.3. Opportunity 3.4. Market trends by Region 3.5. Forecast Factors - Relevance & Impact 3.6. Regulations and Policies 4. Global Market - Pricing Analysis 4.1. Price Point Assessment by Region 4.1.1. Manufacturer Level Pricing 4.1.2. Distributor Level Pricing 4.2. Price Point Assessment by Customer Orientation w.r.t. Functionality 4.3. Price Forecast till 2034 5. Value Chain Analysis 5.1. Operating margins at each node of supply chain 5.2. List of Active Market Participants 6. Global Market Size in Value (US$ billion) and Volume (MT) Analysis 2019 to 2023 and Forecast, 2024 to 2034 6.1. Historical Market Size in Value (US$ billion) and Volume (MT) Analysis, 2019 to 2023 6.2. Current and Future Market Size in Value (US$ billion) and Volume (MT) Analysis, 2024 to 2034 6.2.1. Y-o-Y Growth Trend Analysis 6.2.2. Absolute $ Opportunity Analysis 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Customer Orientation w.r.t. Functionality 7.1. Introduction / Key Findings 7.2. Historical Market Size in Value (US$ billion) and Volume (MT) Analysis by Customer Orientation w.r.t. Functionality, 2019 to 2023 7.3. Current and Future Market Size in Value (US$ billion) and Volume (MT) Analysis and Forecast by Customer Orientation w.r.t. Functionality, 2024 to 2034 7.4. Baby / Infant 7.4.1. Digestive Health 7.4.2. Metabolic Health 7.4.3. Immune Support 7.4.4. Others 7.5. Women 7.5.1. Digestive Health 7.5.2. Gut Brain Axis 7.5.3. Metabolic Health 7.5.4. Others 7.6. Men 7.6.1. Digestive Health 7.6.2. Gut Brain Axis 7.6.3. Metabolic Health 7.6.4. Others 7.7. Unisex 7.7.1. Digestive Health 7.7.2. Gut Brain Axis 7.7.3. Metabolic Health 7.7.4. Others 7.8. Market Attractiveness Analysis by Customer Orientation w.r.t. Functionality 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Bacteria Type 8.1. Introduction / Key Findings 8.2. Historical Market Size in Value (US$ billion) and Volume (MT) Analysis by Bacteria Type, 2019 to 2023 8.3. Current and Future Market Size in Value (US$ billion) and Volume (MT) Analysis and Forecast by Bacteria Type, 2024 to 2034 8.3.1. Lactobacillus 8.3.2. Streptococcus 8.3.3. Bifidobacterium 8.3.4. Bacillus Coagulants 8.3.5. Saccharomyces 8.3.6. Lactococcus Lactis 8.4. Market Attractiveness Analysis by Bacteria Type 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Form 9.1. Introduction / Key Findings 9.2. Historical Market Size in Value (US$ billion) and Volume (MT) Analysis by Form, 2019 to 2023 9.3. Current and Future Market Size in Value (US$ billion) and Volume (MT) Analysis and Forecast by Form, 2024 to 2034 9.3.1. Tablets / Pills 9.3.2. Capsules 9.3.3. Liquid 9.3.4. Powder 9.3.5. Gummies / Chewable 9.3.6. Lozenges 9.3.7. Others (Gels, Soft Gels) 9.4. Market Attractiveness Analysis by Form 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by CFU Count 10.1. Introduction / Key Findings 10.2. Historical Market Size in Value (US$ billion) and Volume (MT) Analysis by CFU Count, 2019 to 2023 10.3. Current and Future Market Size in Value (US$ billion) and Volume (MT) Analysis and Forecast by CFU Count, 2024 to 2034 10.3.1. Less than 1 Billion 10.3.2. 1 Billion to 5 Billion 10.3.3. 5 Billion to 10 Billion 10.3.4. 10 Billion to 20 Billion 10.3.5. 20 Billion to 30 Billion 10.3.6. 30 Billion to 50 Billion 10.3.7. More than 50 Billion 10.4. Market Attractiveness Analysis by CFU Count 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Sales Channel 11.1. Introduction / Key Findings 11.2. Historical Market Size in Value (US$ billion) and Volume (MT) Analysis by Sales Channel, 2019 to 2023 11.3. Current and Future Market Size in Value (US$ billion) and Volume (MT) Analysis and Forecast by Sales Channel, 2024 to 2034 11.3.1. Hypermarkets / Supermarkets 11.3.2. Specialty Stores 11.3.3. E-commerce 11.3.4. Drug Stores & Pharmacies 11.3.5. Health & Wellness Stores 11.3.6. Convenience Stores 11.3.7. Departmental Stores 11.3.8. Others 11.4. Market Attractiveness Analysis by Sales Channel 12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 12.1. Introduction 12.2. Historical Market Size in Value (US$ billion) and Volume (MT) Analysis by Region, 2019 to 2023 12.3. Current Market Size in Value (US$ billion) and Volume (MT) Analysis and Forecast by Region, 2024 to 2034 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East & Africa 12.4. Market Attractiveness Analysis by Region 13. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034 13.1. Introduction 13.2. Historical Market Size (US$ billion) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023 13.3. Market Size (US$ billion) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034 13.3.1. by Country 13.3.1.1. United States 13.3.1.2. Canada 13.3.2. by Customer Orientation w.r.t. Functionality 13.3.3. by Bacteria Type 13.3.4. by Form 13.3.5. by CFU Count 13.3.6. by Sales Channel 13.4. Market Attractiveness Analysis 13.4.1. by Country 13.4.2. by Customer Orientation w.r.t. Functionality 13.4.3. by Bacteria Type 13.4.4. by Form 13.4.5. by CFU Count 13.4.6. by Sales Channel 13.5. Key takeaways 14. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034 14.1. Introduction 14.2. Historical Market Size (US$ billion) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023 14.3. Market Size (US$ billion) and Volume (MT) Forecast by Market Taxonomy, 2024 to 2034 14.3.1. by Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. by Customer Orientation w.r.t. Functionality 14.3.3. by Bacteria Type 14.3.4. by Form 14.3.5. by CFU Count 14.3.6. by Sales Channel 14.4. Market Attractiveness Analysis 14.4.1. by Country 14.4.2. by Customer Orientation w.r.t. Functionality 14.4.3. by Bacteria Type 14.4.4. by Form 14.4.5. by CFU Count 14.4.6. by Sales Channel 14.5. Key takeaways 15. Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034 15.1. Introduction 15.2. Historical Market Size (US$ billion) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023 15.3. Market Size (US$ billion) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034 15.3.1. by Country 15.3.1.1. Germany 15.3.1.2. United Kingdom 15.3.1.3. France 15.3.1.4. Italy 15.3.1.5. Spain 15.3.1.6. BENELUX 15.3.1.7. Nordic 15.3.1.8. Russia 15.3.1.9. Poland 15.3.1.10. Rest of Europe 15.3.2. by Customer Orientation w.r.t. Functionality 15.3.3. by Bacteria Type 15.3.4. by Form 15.3.5. by CFU Count 15.3.6. by Sales Channel 15.4. Market Attractiveness Analysis 15.4.1. by Country 15.4.2. by Customer Orientation w.r.t. Functionality 15.4.3. by Bacteria Type 15.4.4. by Form 15.4.5. by CFU Count 15.4.6. by Sales Channel 15.5. Key takeaways 16. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034 16.1. Introduction 16.2. Historical Market Size (US$ billion) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023 16.3. Market Size (US$ billion) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034 16.3.1. by Country 16.3.1.1. China 16.3.1.2. Japan 16.3.1.3. South Korea 16.3.2. by Customer Orientation w.r.t. Functionality 16.3.3. by Bacteria Type 16.3.4. by Form 16.3.5. by CFU Count 16.3.6. by Sales Channel 16.4. Market Attractiveness Analysis 16.4.1. by Country 16.4.2. by Customer Orientation w.r.t. Functionality 16.4.3. by Bacteria Type 16.4.4. by Form 16.4.5. by CFU Count 16.4.6. by Sales Channel 16.5. Key takeaways 17. South Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034 17.1. Introduction 17.2. Historical Market Size (US$ billion) and Volume (MT) Trend Analysis by Market Taxonomy, 2019 to 2023 17.3. Market Size (US$ billion) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034 17.3.1. by Country 17.3.1.1. India 17.3.1.2. Thailand 17.3.1.3. Malaysia 17.3.1.4. Indonesia 17.3.1.5. Vietnam 17.3.1.6. Philippines 17.3.1.7. Singapore 17.3.1.8. Rest of South Asia 17.3.2. by Customer Orientation w.r.t. Functionality 17.3.3. by Bacteria Type 17.3.4. by Form 17.3.5. by CFU Count 17.3.6. by Sales Channel 17.4. Market Attractiveness Analysis 17.4.1. by Country 17.4.2. by Customer Orientation w.r.t. Functionality 17.4.3. by Bacteria Type 17.4.4. by Form 17.4.5. by CFU Count 17.4.6. by Sales Channel 17.5. Key takeaways 18. Oceania Market Analysis 2019 to 2023 and Forecast 2024 to 2034 18.1. Introduction 18.2. Historical Market Size (US$ billion) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023 18.3. Market Size (US$ billion) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034 18.3.1. by Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. by Customer Orientation w.r.t. Functionality 18.3.3. by Bacteria Type 18.3.4. by Form 18.3.5. by CFU Count 18.3.6. by Sales Channel 18.4. Market Attractiveness Analysis 18.4.1. by Country 18.4.2. by Customer Orientation w.r.t. Functionality 18.4.3. by Bacteria Type 18.4.4. by Form 18.4.5. by CFU Count by Sales Channel 18.5. Key takeaways 19. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034 19.1. Introduction 19.2. Historical Market Size (US$ billion) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023 19.3. Market Size (US$ billion) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034 19.3.1. by Country 19.3.1.1. GCC Countries 19.3.1.2. Turkiye 19.3.1.3. Egypt 19.3.1.4. South Africa 19.3.1.5. Rest of Middle East and Africa 19.3.2. by Customer Orientation w.r.t. Functionality 19.3.3. by Bacteria Type 19.3.4. by Form 19.3.5. by CFU Count 19.3.6. by Sales Channel 19.4. Market Attractiveness Analysis 19.4.1. by Country 19.4.2. by Customer Orientation w.r.t. Functionality 19.4.3. by Bacteria Type 19.4.4. by Form 19.4.5. by CFU Count 19.4.6. by Sales Channel 19.5. Key takeaways 20. Country-level Market Analysis, 2024 20.1. United States Market Analysis 20.1.1. by Customer Orientation w.r.t. Functionality 20.1.2. by Bacteria Type 20.1.3. by Form 20.1.4. by CFU Count 20.1.5. by Sales Channel 20.2. Canada Market Analysis 20.2.1. by Customer Orientation w.r.t. Functionality 20.2.2. by Bacteria Type 20.2.3. by Form 20.2.4. by CFU Count 20.2.5. by Sales Channel 20.3. Brazil Market Analysis 20.3.1. by Customer Orientation w.r.t. Functionality 20.3.2. by Bacteria Type 20.3.3. by Form 20.3.4. by CFU Count 20.3.5. by Sales Channel 20.4. Mexico Market Analysis 20.4.1. by Customer Orientation w.r.t. Functionality 20.4.2. by Bacteria Type 20.4.3. by Form 20.4.4. by CFU Count 20.4.5. by Sales Channel 20.5. Argentina Market Analysis 20.5.1. by Customer Orientation w.r.t. Functionality 20.5.2. by Bacteria Type 20.5.3. by Form 20.5.4. by CFU Count 20.5.5. by Sales Channel 20.6. Germany Market Analysis 20.6.1. by Customer Orientation w.r.t. Functionality 20.6.2. by Bacteria Type 20.6.3. by Form 20.6.4. by CFU Count 20.6.5. by Sales Channel 20.7. United Kingdom Market Analysis 20.7.1. by Customer Orientation w.r.t. Functionality 20.7.2. by Bacteria Type 20.7.3. by Form 20.7.4. by CFU Count 20.7.5. by Sales Channel 20.8. France Market Analysis 20.8.1. by Customer Orientation w.r.t. Functionality 20.8.2. by Bacteria Type 20.8.3. by Form 20.8.4. by CFU Count 20.8.5. by Sales Channel 20.9. Italy Market Analysis 20.9.1. by Customer Orientation w.r.t. Functionality 20.9.2. by Bacteria Type 20.9.3. by Form 20.9.4. by CFU Count 20.9.5. by Sales Channel 20.10. Spain Market Analysis 20.10.1. by Customer Orientation w.r.t. Functionality 20.10.2. by Bacteria Type 20.10.3. by Form 20.10.4. by CFU Count 20.10.5. by Sales Channel 20.11. BENELUX Market Analysis 20.11.1. by Customer Orientation w.r.t. Functionality 20.11.2. by Bacteria Type 20.11.3. by Form 20.11.4. by CFU Count 20.11.5. by Sales Channel 20.12. Nordic Market Analysis 20.12.1. by Customer Orientation w.r.t. Functionality 20.12.2. by Bacteria Type 20.12.3. by Form 20.12.4. by CFU Count 20.12.5. by Sales Channel 20.13. Russia Region Market Analysis 20.13.1. by Customer Orientation w.r.t. Functionality 20.13.2. by Bacteria Type 20.13.3. by Form 20.13.4. by CFU Count 20.13.5. by Sales Channel 20.14. Poland Market Analysis 20.14.1. by Customer Orientation w.r.t. Functionality 20.14.2. by Bacteria Type 20.14.3. by Form 20.14.4. by CFU Count 20.14.5. by Sales Channel 20.15. China Market Analysis 20.15.1. by Customer Orientation w.r.t. Functionality 20.15.2. by Bacteria Type 20.15.3. by Form 20.15.4. by CFU Count 20.15.5. by Sales Channel 20.16. Japan Market Analysis 20.16.1. by Customer Orientation w.r.t. Functionality 20.16.2. by Bacteria Type 20.16.3. by Form 20.16.4. by CFU Count 20.16.5. by Sales Channel 20.17. South Korea Market Analysis 20.17.1. by Customer Orientation w.r.t. Functionality 20.17.2. by Bacteria Type 20.17.3. by Form 20.17.4. by CFU Count 20.17.5. by Sales Channel 20.18. India Market Analysis 20.18.1. by Customer Orientation w.r.t. Functionality 20.18.2. by Bacteria Type 20.18.3. by Form 20.18.4. by CFU Count 20.18.5. by Sales Channel 20.19. Thailand Market Analysis 20.19.1. by Customer Orientation w.r.t. Functionality 20.19.2. by Bacteria Type 20.19.3. by Form 20.19.4. by CFU Count 20.19.5. by Sales Channel 20.20. Malaysia Market Analysis 20.20.1. by Customer Orientation w.r.t. Functionality 20.20.2. by Bacteria Type 20.20.3. by Form 20.20.4. by CFU Count 20.20.5. by Sales Channel 20.21. Indonesia Market Analysis 20.21.1. by Customer Orientation w.r.t. Functionality 20.21.2. by Bacteria Type 20.21.3. by Form 20.21.4. by CFU Count 20.21.5. by Sales Channel 20.22. Vietnam Market Analysis 20.22.1. by Customer Orientation w.r.t. Functionality 20.22.2. by Bacteria Type 20.22.3. by Form 20.22.4. by CFU Count 20.22.5. by Sales Channel 20.23. Philippines Market Analysis 20.23.1. by Customer Orientation w.r.t. Functionality 20.23.2. by Bacteria Type 20.23.3. by Form 20.23.4. by CFU Count 20.23.5. by Sales Channel 20.24. Singapore Market Analysis 20.24.1. by Customer Orientation w.r.t. Functionality 20.24.2. by Bacteria Type 20.24.3. by Form 20.24.4. by CFU Count 20.24.5. by Sales Channel 20.25. Australia Market Analysis 20.25.1. by Customer Orientation w.r.t. Functionality 20.25.2. by Bacteria Type 20.25.3. by Form 20.25.4. by CFU Count 20.25.5. by Sales Channel 20.26. New Zealand Market Analysis 20.26.1. by Customer Orientation w.r.t. Functionality 20.26.2. by Bacteria Type 20.26.3. by Form 20.26.4. by CFU Count 20.26.5. by Sales Channel 20.27. GCC Countries Market Analysis 20.27.1. by Customer Orientation w.r.t. Functionality 20.27.2. by Bacteria Type 20.27.3. by Form 20.27.4. by CFU Count 20.27.5. by Sales Channel 20.28. Turkiye Market Analysis 20.28.1. by Customer Orientation w.r.t. Functionality 20.28.2. by Bacteria Type 20.28.3. by Form 20.28.4. by CFU Count 20.28.5. by Sales Channel 20.29. Egypt Market Analysis 20.29.1. by Customer Orientation w.r.t. Functionality 20.29.2. by Bacteria Type 20.29.3. by Form 20.29.4. by CFU Count 20.29.5. by Sales Channel 20.30. South Africa Market Analysis 20.30.1. by Customer Orientation w.r.t. Functionality 20.30.2. by Bacteria Type 20.30.3. by Form 20.30.4. by CFU Count 20.30.5. by Sales Channel 21. Market Structure Analysis 21.1. Global Market Competition - a Dashboard View 21.2. Industry Structure Analysis 21.2.1. % tier 1 Market players 21.2.2. % tier 2 Market players 21.2.3. % tier 3 Market players 21.3. Global Market Company Share Analysis 21.3.1. For Tier 1 Market Players, 2024 21.3.2. Company Market Share Analysis of Top 5 Players, by Region 21.4. Key Participants Market Presence (Intensity Mapping) by Region 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep Dive 22.3.1. Culturelle (i-Health, Inc.) 22.3.1.1. Source Portfolio 22.3.1.2. Source Claim 22.3.1.3. Revenue by Market Segments (Source/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.1.5.1. Probiotic Supplementing Strategy 22.3.1.5.2. Source Strategy 22.3.1.5.3. Channel Strategy 22.3.1.6. SWOT Analysis 22.3.2. Align 22.3.3. Billion Cheers (Fermentis Life Sciences Pvt Ltd) 22.3.4. Digestive Advantage 22.3.5. Garden of Life (Nestle SA) 22.3.6. Spring Valley 22.3.7. Now Foods 22.3.8. Nature Made 22.3.9. HUM Nutrition Inc. 22.3.10. OLLY 22.3.11. Ora Organics 22.3.12. Natrol 22.3.13. Others (on additional request) 23. Assumptions and Acronyms 24. Research Methodology
Explore Food and Beverage Insights
View Reports